Stoke Therapeutics Inc at Needham Neuroscience Forum (Virtual) Transcript
Good afternoon, everyone. Thank you for joining the Second Annual Needham Neuroscience Forum. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Stoke Therapeutics. Joining us today from Stoke is CEO, Ed Kaye; and CMO, Barry Ticho. (Conference Instructions)
Questions & Answers
So with that, we'll go ahead and get started. Ed and Barry, thank you so much for joining us today. Given that this is a neuroscience forum, we'll start with some high-level industry questions and then we'll get into more company-specific programs.
So it's been said many times that neuroscience is going through a renaissance. What do you believe has been the most important successes to date? And where do you believe more progress needs to be made?
Well, I think it's always interesting
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |